OBESITY TYPE 2 DIABETES MELLITUS
Clinical trials for OBESITY TYPE 2 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new OBESITY TYPE 2 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for OBESITY TYPE 2 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug trial aims to shed pounds and control blood sugar
Disease control Recruiting nowThis study is testing whether a new medication called aleniglipron is safe and helps with weight loss and blood sugar control in adults with type 2 diabetes who are overweight or have obesity. About 50 participants will take either the drug or a placebo (inactive pill) daily for …
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists investigate: what do people really eat on popular weight loss drugs?
Knowledge-focused Recruiting nowThis study aims to understand how people's eating habits and diet quality change when they start taking GLP-1 medications for weight loss or diabetes. Researchers will follow 50 adults who are about to begin these medications, tracking what they eat and how they feel about their …
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Sponsor: University of South Carolina • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:40 UTC